S
Stefan Schneeberger
Researcher at Innsbruck Medical University
Publications - 267
Citations - 6833
Stefan Schneeberger is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 40, co-authored 221 publications receiving 5546 citations. Previous affiliations of Stefan Schneeberger include University of Pittsburgh & University of Innsbruck.
Papers
More filters
Journal ArticleDOI
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Gerald Brandacher,Alexander Perathoner,Ruth Ladurner,Ruth Ladurner,Stefan Schneeberger,Peter Obrist,Christiana Winkler,Ernst R. Werner,Gabriele Werner-Felmayer,Helmut Weiss,Georg Göbel,Raimund Margreiter,Alfred Königsrainer,Alfred Königsrainer,Dietmar Fuchs,Albert Amberger +15 more
TL;DR: IDO-high expression by colorectal tumor cells enables certain cancer subsets to initially avoid immune attack and defeat the invasion of T cells via local tryptophan depletion and the production of proapoptotic tryPTophan catabolites.
Journal ArticleDOI
The Banff 2007 working classification of skin-containing composite tissue allograft pathology.
Linda C. Cendales,Jean Kanitakis,Stefan Schneeberger,Stefan Schneeberger,Carolyn Burns,Philip Ruiz,Luis Landin,Myriam Remmelink,Charles W. Hewitt,T. Landgren,B. Lyons,Cinthia B. Drachenberg,Kim Solez,Allan D. Kirk,David E. Kleiner,Lorraine C. Racusen +15 more
TL;DR: A working classification is proposed, the Banff CTA‐07, for the categorization of CTA rejection, derived from a consensus discussion session attended by the first authors of three published classification systems, pathologists and researchers from international centers where clinical CTA has been performed.
Journal ArticleDOI
2018 annual report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation
René Adam,Vincent Karam,Valérie Cailliez,John G. O Grady,Darius F. Mirza,Daniel Cherqui,Jürgen Klempnauer,Mauro Salizzoni,Johann Pratschke,Neville V. Jamieson,Ernest Hidalgo,Andreas Paul,Rafael López Andújar,Jan Lerut,Lutz Fisher,Karim Boudjema,Constantino Fondevila,Olivier Soubrane,Philippe Bachellier,Antonio Daniele Pinna,Gabriela A. Berlakovich,William Bennet,Massimo Pinzani,Peter Schemmer,Krzysztof Zieniewicz,Carlos Jimenez Romero,Paolo De Simone,Bo-Göran Ericzon,Stefan Schneeberger,Stephen J. Wigmore,Joan Fabregat Prous,Michele Colledan,Robert J. Porte,Sezai Yilmaz,Daniel Azoulay,Jacques Pirenne,Pål-Dag Line,Pavel Trunecka,Francis Navarro,Andres Valdivieso Lopez,Luciano De Carlis,Sebastian Rufian Pena,Eberhard Kochs,Christophe Duvoux +43 more
TL;DR: An overview of trends and results of liver transplantation in Europe from 1968 to 2016 is provided, as well as information on evolution of techniques, and outcomes in LT in Europe over more than five decades is provided.
Journal ArticleDOI
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
James Neuberger,Wolf O. Bechstein,Dirk Kuypers,Patrizia Burra,Franco Citterio,Sabina De Geest,Christophe Duvoux,Alan G. Jardine,Nassim Kamar,Bernhard K. Krämer,Herold J. Metselaar,Frederik Nevens,Jacques Pirenne,Manuel Rodríguez-Perálvarez,Didier Samuel,Stefan Schneeberger,Daniel Serón,Pavel Trunecka,Giuseppe Tisone,Teun van Gelder +19 more
TL;DR: In this article, the authors provide specific, practical recommendations, through the discussion of current evidence and best practice, for the management of modifiable risks in those kidney and liver transplant patients who have survived the first postoperative year.
Journal ArticleDOI
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.
Stefan Schneeberger,Stefan Schneeberger,Stefan Schneeberger,Vijay S. Gorantla,Gerald Brandacher,Gerald Brandacher,Gerald Brandacher,Adriana Zeevi,Anthony J. Demetris,John G. Lunz,Diana Metes,Albert D. Donnenberg,Jaimie T. Shores,Andrea DiMartini,Joseph E. Kiss,Joseph E. Imbriglia,Kodi Azari,Robert J. Goitz,Ernest K. Manders,Vu T. Nguyen,Damon S. Cooney,Galen S. Wachtman,Jonathan D. Keith,Derek R. Fletcher,Camila Macedo,Raymond M. Planinsic,Joseph E. Losee,Ron Shapiro,Thomas E. Starzl,W. P. Andrew Lee,W. P. Andrew Lee +30 more
TL;DR: The data suggest that this BM cell-based treatment protocol is safe, is well tolerated, and allows upper-extremity transplantation using low-dose tacrolimus monotherapy.